Compassus

Consider the strange economics of hospice. It is, in the most literal sense, a business with no repeat customers. You cannot upsell, cannot cross-sell a renewal, cannot win the account back next quarter. The service is provided once, at the end, and then the relationship is over. And yet somebody has to build the company that does this - at scale, across state lines, with payroll and compliance and a call schedule - because roughly everyone eventually needs it. Compassus is one of the largest somebodies.

Headquartered in Brentwood, Tennessee, Compassus provides four things that all share an address: your home. There is hospice - comfort-focused care for people near the end of life, plus grief support for the families they leave. There is palliative care - relief from the symptoms and stress of serious illness, delivered alongside treatment meant to cure. There is home health - the skilled nursing and therapy that keeps people out of the hospital. And there is home infusion - IV medication administered in a kitchen instead of a clinic. Most competitors pick one lane. Compassus runs all four, on the theory that a family who needs one will eventually need the others and would rather not switch companies to get them.

The tagline is the strategy: "Providence at Home with Compassus." The health system keeps its name out front. Compassus runs the machine behind it.

Here is the part worth slowing down for. Compassus does not grow the way you might expect a private-equity-backed roll-up to grow - by buying up every mom-and-pop agency in a metro and stapling them together. It grows by partnering with the hospital it might otherwise compete with. A health system like OhioHealth or Providence contributes its existing home-health and hospice locations into a jointly owned venture; Compassus takes over operations and management; and the result gets a co-branded name that keeps the hospital's reputation out front while Compassus does the unglamorous work of running it. The health system keeps the patient relationship. Compassus gets scale and referral flow. Everybody, at least in theory, keeps their comparative advantage.

It is an elegant arrangement, and the ownership structure makes it more so. Since 2019, Compassus has been jointly owned by the private-equity firm TowerBrook Capital Partners and Ascension, one of the largest nonprofit Catholic health systems in the country, in a deal reported at around a billion dollars. Ascension is not only a co-owner - it is also a customer, having made Compassus its preferred provider of hospice services. When your customer decides to buy the company rather than just the service, that tells you something about how sticky the service is.

There is a quiet truth underneath American healthcare's shift to "value-based care": the money is increasingly in keeping people out of the hospital, not in filling beds. Payers reward the provider who manages a patient well enough that they don't get readmitted. Compassus is built precisely for that world. The more care that happens at home - safely, at lower acuity, without a 3 a.m. ambulance - the better the company does. Its financial interest and the patient's interest point, unusually, in the same direction.

Scaling compassion sounds like an oxymoron. Compassus is the ongoing experiment in whether you can run tender, personal care as a 30-state operation without losing the tender part.

That is also the hardest thing about the business, and Compassus seems to know it. Hospice and home health are labor - a nurse in a car, an aide at a bedside, a chaplain on the phone with a daughter. There is no software that delivers the visit. Which is why the company treats workforce retention as a clinical strategy, not just an HR line item: a burned-out caregiver delivers worse care, and in this line of work "worse care" has a very human meaning. Its appearance on Newsweek's America's Greatest Workplaces list is, for a hospice operator, closer to a quality metric than a vanity badge.

Mike Asselta leads Compassus as Chief Executive Officer, with a senior team including COO/Presidents Laura Templeton (West) and B. Andrew Pate (East), CFO John Cullen, Chief Medical Officer Kurt Merkelz, and Chief People Officer Priscila Feijó Mattingly. The competitive set - AccentCare, Amedisys, Enhabit, Gentiva, VITAS, Option Care Health - is a reminder that home-based care is one of the most contested corners of American healthcare right now.